Gastroprotective effect of cochinchina momordica seed extract in nonsteroidal anti-inflammatory drug-induced acute gastric damage in a rat model

Gut and Liver

Volumn 8, Issue 1, 2014, Pages 49-57

  Lim, Ji Hwan ^a   Kim, Joo Hyun ^b   Kim, Nayoung ^a,c   Lee, Byoung Hwan ^a   Seo, Pyoung Ju ^a   Kang, Jung Mook ^c   Jo, So Young ^a   Park, Ji Hyun ^c   Nam, Ryoung Hee ^a   Chang, Hyun ^a   Kwon, Jin Won ^d   Lee, Dong Ho ^a,c  

^a Seoul National University Bundang Hospital   (South Korea)

^b SK Chemicals   (South Korea)

^c Seoul National University   (South Korea)

^d Kyungpook National University   (South Korea)

Author keywords

Anti inflammatory agents non steroidal; Arachidonate 5 lipoxygenase; Cochinchina momordica; Gastroprotection; Phospholipases A2 cytosolic

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ARACHIDONATE 5 LIPOXYGENASE; CALCITONIN GENE RELATED PEPTIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; DICLOFENAC; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; INDOMETACIN; MESSENGER RNA; MOMORDICA COCHINCHINENSIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG INDUCED DISEASE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHANOL-INDUCED GASTRIC ULCER; IMAGE ANALYSIS; MALE; MOMORDICA COCHINCHINENSIS; NONHUMAN; PLANT SEED; PROTEIN EXPRESSION; RAT; STOMACH INJURY; STOMACH PROTECTION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; COCHINCHINA MOMORDICA; GASTROPROTECTION; PHOSPHOLIPASES A2, CYTOSOLIC;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; CALCITONIN GENE-RELATED PEPTIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; GROUP IV PHOSPHOLIPASES A2; MALE; MOMORDICA; PEROXIDASE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; STOMACH ULCER; TREATMENT OUTCOME;

EID: 84893107223     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2014.8.1.49     Document Type: Article

References (36)

1. Allen A, Flemström G, Garner A, Kivilaakso E. Gastroduodenal mucosal protection. Physiol Rev 1993;73:823-857.
2. Flemstrom G, Garner A. Gastroduodenal HCO3(-) transport: characteristics and proposed role in acidity regulation and mucosal protection. Am J Physiol 1982;242:G183-G193.
3. Arakawa T, Higuchi K, Fujiwara Y, et al. 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci 2005;50 Suppl 1:S3-S11.
4. McCarthy DM. Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol 2010;26:624-631.
5. Beck PL, Xavier R, Lu N, et al. Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology 2000;119:699-705.
6. Yoshikawa T, Naito Y, Kishi A, et al. Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993;34:732-737.
7. Yoshida N, Yoshikawa T, Nakamura Y, et al. Role of neutrophil-mediated inflammation in aspirin-induced gastric mucosal injury. Dig Dis Sci 1995;40:2300-2304.
8. Takeuchi K, Tanaka A, Hayashi Y, Kubo Y. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility. Dig Dis Sci 2004;49:180-187.
9. Tanaka J, Yuda Y, Yamakawa T. Mechanism of superoxide generation system in indomethacin-induced gastric mucosal injury in rats. Biol Pharm Bull 2001;24:155-158.
10. Okada A, Kinoshita Y, Waki S, et al. Rat gastric mucosal cells express ICAM-1 and proinflammatory cytokines during indomethacin-induced mucosal injury. J Lab Clin Med 1998;131:538-547.
11. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci 1998;43(9 Suppl):5S-13S.
12. Choi SM, Shin JH, Kang KK, Ahn BO, Yoo M. Gastroprotective effects of DA-6034, a new flavonoid derivative, in various gastric mucosal damage models. Dig Dis Sci 2007;52:3075-3080.
13. Matsuda H, Li Y, Murakami T, Yamahara J, Yoshikawa M. Protective effects of oleanolic acid oligoglycosides on ethanol- or indomethacin-induced gastric mucosal lesions in rats. Life Sci 1998;63:PL245-PL250.
14. Kang JM, Kim N, Kim B, et al. Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)/5-LOX pathway. Dig Dis Sci 2009;54:2549-2560.
15. Seo PJ, Kim N, Kim JH, et al. Comparison of indomethacin, diclofenac and aspirin-induced gastric damage according to age in rats. Gut Liver 2012;6:210-217.
16. Choi KS, Kim EH, Hong H, et al. Attenuation of cysteamine-induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A2/5-lipoxygenase and activating gamma- glutamylcysteine synthetase. J Gastroenterol Hepatol 2012;27 Suppl 3:13-22.
17. Ichikawa T, Ishihara K, Kusakabe T, Hiruma H, Kawakami T, Hotta K. CGRP modulates mucin synthesis in surface mucus cells of rat gastric oxyntic mucosa. Am J Physiol Gastrointest Liver Physiol 2000;279:G82-G89.
18. Lambrecht N, Burchert M, Respondek M, Müller KM, Peskar BM. Role of calcitonin gene-related peptide and nitric oxide in the gastroprotective effect of capsaicin in the rat. Gastroenterology 1993;104:1371-1380.
19. Gyires K, Hermecz I, Knoll J. The effect of some anti-ulcer agents on the early vascular injury of gastric mucosa induced by ethanol in rats. Acta Physiol Hung 1989;73:149-154.
20. Szabo S, Trier JS, Brown A, Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 1985;88(1 Pt 2):228-236.
21. Peskar BM, Maricic N. Role of prostaglandins in gastroprotection. Dig Dis Sci 1998;43(9 Suppl):23S-29S.
22. Buttgereit F, Burmester GR, Simon LS. Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors. Am J Med 2001;110 Suppl 3A:13S-19S.
23. Suleyman H, Albayrak A, Bilici M, Cadirci E, Halici Z. Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers. Inflammation 2010;33:224-234.
24. Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 1999;106(5B):37S-42S.
25. Brzozowski T, Konturek PC, Konturek SJ, et al. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc Res Tech 2001;53:343-353.
26. Gambero A, Maróstica M, Becker TL, Pedrazzoli J Jr. Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol. Dig Dis Sci 2007;52:425-433.
27. Jang SW, Lee JW, Park SH, et al. Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis. Int J Pharm 2008;356:88-94.
28. Graumlich JF. Preventing gastrointestinal complications of NSAIDs. Risk factors, recent advances, and latest strategies. Postgrad Med 2001;109:117-128.
29. DeWitt DL, Meade EA, Smith WL. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am J Med 1993;95(2A):40S-44S.
30. Clària J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci U S A 1995;92:9475-9479.
31. Tanaka A, Araki H, Hase S, Komoike Y, Takeuchi K. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury. Aliment Pharmacol Ther 2002;16 Suppl 2:90-101.
32. DiJoseph JF, Eash JR, Mir GN. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity. J Pharmacol Exp Ther 1987;241:97-102.
33. Zayachkivska OS, Konturek SJ, Drozdowicz D, Konturek PC, Brzozowski T, Ghegotsky MR. Gastroprotective effects of flavonoids in plant extracts. J Physiol Pharmacol 2005;56 Suppl 1:219-231.
34. Chatterjee A, Chattopadhyay S, Bandyopadhyay SK. Biphasic effect of phyllanthus emblica L. extract on NSAID-induced ulcer: an antioxidative trail weaved with immunomodulatory effect. Evid Based Complement Alternat Med 2011;2011:146808.
35. Hsu DZ, Chu PY, Li YH, Liu MY. Sesamol attenuates diclofenac-induced acute gastric mucosal injury via its cyclooxygenase-independent antioxidative effect in rats. Shock 2008;30:456-462.
36. Blandizzi C, Fornai M, Colucci R, et al. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 2005;11:4052-4060.